| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $487K | +3130.4% |
| Cost of Revenue | $113K | +555.3% |
| R&D Expense | $2.7M | — |
| SG&A Expense | $12.5M | +178.0% |
| Operating Income | -$14.8M | -228.7% |
| Interest Expense | $102 | -79.9% |
| Pre-tax Income | -$13.9M | -541.2% |
| Net Income | -$13.9M | -541.2% |
| EPS (Basic) | -$0.55 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.1M | -37.4% |
| Current Assets | $34.1M | -36.1% |
| Total Assets | $45.2M | -15.3% |
| Current Liabilities | $1.9M | +319.8% |
| Total Liabilities | $2.7M | +41.1% |
| Stockholders' Equity | $42.5M | -17.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.6M | -358.8% |
| Capital Expenditures | $375K | +1643.4% |
| Investing Cash Flow | -$2.1M | -9487.2% |
| Financing Cash Flow | -$3.2M | -105.7% |
| Free Cash Flow | -$14.9M | -367.4% |
| -161.9% |
| EPS (Diluted) | -$0.53 | -152.4% |